English  |  正體中文  |  简体中文  |  總筆數 :2851816  
造訪人次 :  44933611    線上人數 :  1376
教育部委託研究計畫      計畫執行:國立臺灣大學圖書館
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
關於TAIR

瀏覽

消息

著作權

相關連結

"tseng c h"的相關文件

回到依作者瀏覽
依題名排序 依日期排序

顯示項目 276-285 / 531 (共54頁)
<< < 23 24 25 26 27 28 29 30 31 32 > >>
每頁顯示[10|25|50]項目

機構 日期 題名 作者
臺大學術典藏 2020-11-02T02:05:01Z Abdominal distension in a patient with Crohn's disease Tseng C.-H.; Liu K.-L.; Liou J.-M.; W H.-P.; MING-SHIANG WU
臺大學術典藏 2020-11-02T02:04:57Z Early risk stratification with simple clinical parameters for cirrhotic patients with acute upper gastrointestinal bleeding Wang H.-P.; MING-SHIANG WU; Chen C.-C.; Lin T.-L.; Tseng C.-H.; Chung C.-S.; Liou J.-M.; Hsu Y.-C.
臺大學術典藏 2020-11-02T02:04:47Z Sequential versus triple therapy for the first-line treatment of Helicobacter pylori: A multicentre, open-label, randomised trial MING-SHIANG WU; Lee Y.-C.; Liou J.-M.; Chen C.-C.; Chen M.-J.; Chen C.-C.; Chang C.-Y.; Fang Y.-J.; Lee J.-Y.; Hsu S.-J.; Luo J.-C.; Chang W.-H.; Hsu Y.-C.; Tseng C.-H.; Tseng P.-H.; Wang H.-P.; Yang U.-C.; Shun C.-T.; Lin J.-T.
臺大學術典藏 2020-11-02T02:04:45Z Efficacy of genotypic resistance-guided sequential therapy in the third-line treatment of refractory Helicobacter pylori infection: A multicentre clinical trial Tai C.-M.; Wang Y.-C.; Wang C.-H.; Kuo S.-H.; Wu C.-Y.; Chang W.-H.; Wang H.-P.; Shun C.-T.; Wu J.-Y.; Lee Y.-C.; Lin J.-T.; MING-SHIANG WU; Lin C.-H.; Chow L.-P.; Cheng T.-Y.; Wu C.-Y.; Lee Ching-Tai C.-T, Wang W.-L.; Liou J.-M.; Chen C.-C.; Chang C.-Y.; Chen M.-J.; Fang Y.-J.; Lee J.-Y.; Chen C.-C.; Hsu S.-J.; Hsu Y.-C.; Tseng C.-H.; Tseng P.-H.; Chang L.
臺大學術典藏 2020-11-02T02:04:44Z The benefit of pretreatment esophageal screening with image-enhanced endoscopy on the survival of patients with hypopharyngeal cancer Wang W.-L.; Wang C.-P.; Wang H.-P.; Lee C.-T.; Chang C.-Y.; Tai C.-M.; Tseng C.-H.; Hwang T.-Z.; Wang C.-C.; Lin J.-T.; Lee Y.-C.; MING-SHIANG WU; Lou P.-J.; Ko J.-Y.; Lee J.-M.; Chiu H.-M.; Tseng P.-H.; Lo J.-L.
臺大學術典藏 2020-11-02T02:04:33Z The primary resistance of Helicobacter pylori in Taiwan after the national policy to restrict antibiotic consumption and its relation to virulence factors - A nationwide study Lee Y.-C.; Wang W.-L.; Lee C.-T.; Tai C.-M.; MING-SHIANG WU; Bair M.-J.; Lin J.-T.; Sheu B.-S.; Wang H.-P.; Chang C.-C.; Yang T.-H.; Wu C.-Y.; Liou J.-M.; Chang C.-Y.; Chen M.-J.; Chen C.-C.; Fang Y.-J.; Lee J.-Y.; Wu J.-Y.; Luo J.-C.; Liou T.-C.; Chang W.-H.; Tseng C.-H.; Helicobacter Consortium; Taiwan Gastrointestinal Disease; Wang Y.-C.
臺大學術典藏 2020-11-02T02:04:26Z Sequential therapy for 10 days versus triple therapy for 14 days in the eradication of Helicobacter pylori in the community and hospital populations: A randomised trial Helicobacter Consortium; Fang Y.-J.; Lee J.-Y.; Yang T.-H.; Luo J.-C.; Wu J.-Y.; Liou T.-C.; Chang W.-H.; Hsu Y.-C.; Tseng C.-H.; Chang C.-C.; Bair M.-J.; Liu T.-Y.; Hsieh C.-F.; Tsao F.-Y.; Shun C.-T.; Lin J.-T.; Lee Y.-C.; MING-SHIANG WU; the Taiwan Gastrointestinal Disease; Liou J.-M.; Chen C.-C.; Chang C.-Y.; Chen M.-J.; Chen C.-C.
臺大學術典藏 2020-11-02T02:04:25Z Concomitant, bismuth quadruple, and 14-day triple therapy in the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial Chen C.-Y.; Chen P.-Y.; Shun C.-T.; Hsu W.-F.; Hu W.-H.; Chen Y.-N.; Sheu B.-S.; Lin J.-T.; Wu J.-Y.; El-Omar E.M.; MING-SHIANG WU; Taiwan Gastrointestinal Disease; Helicobacter Consortium; Chang C.-C.; Luo J.-C.; Yang T.-H.; Lee J.-Y.; Hsu Y.-C.; Chen C.-C.; Tseng C.-H.; Chen M.-J.; Lee Y.-C.; Chang C.-Y.; Bair M.-J.; Chen C.-C.; Fang Y.-J.; Liou J.-M.
臺大學術典藏 2020-11-02T02:04:21Z Serum viral load at the virological relapse predicts subsequent clinical flares in chronic hepatitis B patients off entecavir therapy Lin J.-T.; Wu C.-Y.; Lin C.-W.; Tai C.-M.; Chen C.-C.; Tseng C.-H.; Kao J.-H.; Yang T.-H.; MING-SHIANG WU; Chang C.-Y.; Mo L.-R.; Hsu Y.-C.
臺大學術典藏 2020-11-02T02:04:19Z 14 Day sequential therapy versus 10 day bismuth quadruple therapy containing high-dose esomeprazole in the first-line and second-line treatment of Helicobacter pylori: A multicentre, non-inferiority, randomized trial Liou J.-M.; Chen C.-C.; Fang Y.-J.; Chen P.-Y.; Chang C.-Y.; Chou C.-K.; Chen M.-J.; Tseng C.-H.; Lee J.-Y.; Yang T.-H.; Chiu M.-C.; Yu J.-J.; Kuo C.-C.; Luo J.-C.; Hsu W.-F.; Helicobacter Consortium; Taiwan Gastrointestinal Disease; MING-SHIANG WU; Bair M.-J.; Lee Y.-C.; Hu W.-H.; Tsai M.-H.; Lin J.-T.; Shun C.-T.; Twu G.

顯示項目 276-285 / 531 (共54頁)
<< < 23 24 25 26 27 28 29 30 31 32 > >>
每頁顯示[10|25|50]項目